FIELD: chemistry.
SUBSTANCE: invention relates to novel aminopyrimidine compounds of formula (I) having the properties of an inhibitor of PI3-kinase, in particular PI3Kδ. Compounds are intended to regulate, treat or alleviate the severity of a disease caused by inadequate PI3 kinase activity by administering a therapeutically effective amount of the compound. In compounds of formula (I) X is a monovalent heteroaryl group selected from the structures:
and where X is substituted with 1 or 2 R1 groups; Y is
,
each R1 is independently H, -C(= O)NRaRb, (C1-C6)alkyl or (C3-C8)cycloalkyl; R3 is H; R4 is (C1-C6)alkyl; and Ra and Rb are independently H, (C1-C3)alkyl, (C2-C4)alkenyl, (C2-C4)alkynyl, (C3-C6)cycloalkyl, (C3-C5)heterocyclyl or 5-6-membered heteroaryl, where each of (C1-C3)alkyl, (C2-C4)alkenyl, (C2-C4)alkynyl, (C3-C6)cycloalkyl, (C3-C5)heterocyclyl and 5-6 membered heteroaryl is substituted with 1, 2, 3 or 4 substituents independently selected from F, CN, OH, NH2, (C1-C3)alkyl, (C1-C3)haloalkyl, (C1-C3)alkoxy and (C1-C3)alkylamino.
EFFECT: compounds can be used to treat diseases such as asthma, chronic obstructive pulmonary disease (COPD), viral respiratory infections, viral exacerbations of respiratory diseases, aspergillosis, leishmaniasis, allergic rhinitis,
atopic dermatitis, rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, hemoblastosis, pancreatitis, nephropathy, carcinoma, graft rejection, tissue rejection, lung injury, pain caused by rheumatoid arthritis, osteoarthritis, back pain, pain caused by a common inflammatory process, post-hepatic neuralgia, diabetic neuropathy, inflammatory neuropathic pain (trauma), trigeminal neuralgia or central pain.
12 cl, 5 tbl, 70 ex
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE | 2014 |
|
RU2683793C2 |
NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES AND USE THEREOF IN MEDICINAL PREPARATIONS | 2014 |
|
RU2694254C1 |
NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES AND USE THEREOF IN PHARMACEUTICAL PREPARATIONS | 2013 |
|
RU2701156C2 |
BICYCLIC NITROIMIDAZOLES COVALENTLY CONNECTED TO REPLACED PHENYLOXAZOLYDINONES | 2009 |
|
RU2504547C2 |
NOVEL PYRIDOPYRIMIDINONE COMPOUNDS FOR MODULATION OF CATALYTIC ACTIVITY OF HISTONE LYSINE DEMETHYLASES (KDMS) | 2015 |
|
RU2684396C2 |
ANTIVIRAL COMPOUND | 2006 |
|
RU2441010C2 |
[1,8]NAPHTHYRIDINE DERIVATIVES, USEFUL AS INHIBITORS OF HCV VIRUS REPLICATION | 2006 |
|
RU2467007C2 |
INHIBITOR COMPOUNDS | 2013 |
|
RU2673079C2 |
AZABICYCLIC AND DIAZEPINE DERIVATIVES FOR THE TREATMENT OF OPHTHALMIC DISORDERS | 2018 |
|
RU2795521C2 |
NOVEL DERIVATIVES OF MANDELIC ACID AND THEIR USING AS THROMBIN INHIBITORS | 2001 |
|
RU2300521C2 |
Authors
Dates
2018-12-17—Published
2014-09-17—Filed